Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Sep;51(9):643–648. doi: 10.1136/jcp.51.9.643

Human papillomavirus infection with particular reference to genital disease.

C Sonnex 1
PMCID: PMC500898  PMID: 9930065

Abstract

HPV is the commonest sexually transmitted viral infection in the United Kingdom and as such poses a major public health problem. In addition to the potential physical morbidity associated with genital warts, abnormal cervical cytology, and anogenital dysplasia and neoplasia, the associated psychological morbidity should not be forgotten. Although our knowledge of viral function and disease pathogenesis has advanced appreciably in recent years, we are still some way from developing an in vitro method of viral propagation. Vaccination against HPV infection will hopefully be achieved within the next 10 years, but a prevention and treatment strategy which is appropriate for both developed and developing nations must be our major long term goal.

Full text

PDF
643

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alloub M. I., Barr B. B., McLaren K. M., Smith I. W., Bunney M. H., Smart G. E. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ. 1989 Jan 21;298(6667):153–156. doi: 10.1136/bmj.298.6667.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beer-Romero P., Glass S., Rolfe M. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene. 1997 Feb 6;14(5):595–602. doi: 10.1038/sj.onc.1200872. [DOI] [PubMed] [Google Scholar]
  3. Berg M., Stenlund A. Functional interactions between papillomavirus E1 and E2 proteins. J Virol. 1997 May;71(5):3853–3863. doi: 10.1128/jvi.71.5.3853-3863.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borysiewicz L. K., Fiander A., Nimako M., Man S., Wilkinson G. W., Westmoreland D., Evans A. S., Adams M., Stacey S. N., Boursnell M. E. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet. 1996 Jun 1;347(9014):1523–1527. doi: 10.1016/s0140-6736(96)90674-1. [DOI] [PubMed] [Google Scholar]
  5. Brinton L. A., Huggins G. R., Lehman H. F., Mallin K., Savitz D. A., Trapido E., Rosenthal J., Hoover R. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer. 1986 Sep 15;38(3):339–344. doi: 10.1002/ijc.2910380307. [DOI] [PubMed] [Google Scholar]
  6. Carter J. J., Koutsky L. A., Wipf G. C., Christensen N. D., Lee S. K., Kuypers J., Kiviat N., Galloway D. A. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis. 1996 Nov;174(5):927–936. doi: 10.1093/infdis/174.5.927. [DOI] [PubMed] [Google Scholar]
  7. Chang F., Kosunen O., Kosma V. M., Syrjänen S., Lahtinen J., Syrjänen K. Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report. Genitourin Med. 1990 Oct;66(5):342–345. doi: 10.1136/sti.66.5.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen S. L., Mounts P. Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells. J Virol. 1990 Jul;64(7):3226–3233. doi: 10.1128/jvi.64.7.3226-3233.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chua K. L., Wiklund F., Lenner P., Angström T., Hallmans G., Bergman F., Sapp M., Schiller J., Wadell G., Hjerpe A. A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. Int J Cancer. 1996 Sep 27;68(1):54–59. doi: 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  10. Clavel C., Rihet S., Masure M., Chypre C., Boulanger J. C., Quereux C., Birembaut P. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR. J Clin Pathol. 1998 Jan;51(1):38–43. doi: 10.1136/jcp.51.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coleman N., Birley H. D., Renton A. M., Hanna N. F., Ryait B. K., Byrne M., Taylor-Robinson D., Stanley M. A. Immunological events in regressing genital warts. Am J Clin Pathol. 1994 Dec;102(6):768–774. doi: 10.1093/ajcp/102.6.768. [DOI] [PubMed] [Google Scholar]
  12. Cox J. T. HPV DNA testing: clinical boon or boondoggle? Lancet. 1995 Sep 16;346(8977):717–719. doi: 10.1016/s0140-6736(95)91498-6. [DOI] [PubMed] [Google Scholar]
  13. Crum C. P., Liskow A., Petras P., Keng W. C., Frick H. C., 2nd Vulvar intraepithelial neoplasia (severe atypia and carcinoma in situ). A clinicopathologic analysis of 41 cases. Cancer. 1984 Oct 1;54(7):1429–1434. doi: 10.1002/1097-0142(19841001)54:7<1429::aid-cncr2820540733>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  14. Crusius K., Auvinen E., Alonso A. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene. 1997 Sep 18;15(12):1437–1444. doi: 10.1038/sj.onc.1201312. [DOI] [PubMed] [Google Scholar]
  15. Desaintes C., Demeret C., Goyat S., Yaniv M., Thierry F. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 1997 Feb 3;16(3):504–514. doi: 10.1093/emboj/16.3.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Doorbar J., Coneron I., Gallimore P. H. Sequence divergence yet conserved physical characteristics among the E4 proteins of cutaneous human papillomaviruses. Virology. 1989 Sep;172(1):51–62. doi: 10.1016/0042-6822(89)90106-2. [DOI] [PubMed] [Google Scholar]
  17. Doorbar J., Evans H. S., Coneron I., Crawford L. V., Gallimore P. H. Analysis of HPV-1 E4 gene expression using epitope-defined antibodies. EMBO J. 1988 Mar;7(3):825–833. doi: 10.1002/j.1460-2075.1988.tb02881.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Evander M., Edlund K., Gustafsson A., Jonsson M., Karlsson R., Rylander E., Wadell G. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis. 1995 Apr;171(4):1026–1030. doi: 10.1093/infdis/171.4.1026. [DOI] [PubMed] [Google Scholar]
  19. Evander M., Frazer I. H., Payne E., Qi Y. M., Hengst K., McMillan N. A. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 1997 Mar;71(3):2449–2456. doi: 10.1128/jvi.71.3.2449-2456.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Evans B. A., Dawson S. G., McLean K. A., Teece S. A., Key P. R., Bond R. A., Macrae K. D., Jesson W. J., Mortimer P. P. Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Genitourin Med. 1986 Dec;62(6):384–389. doi: 10.1136/sti.62.6.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Farthing A., Masterson P., Mason W. P., Vousden K. H. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol. 1994 Jul;47(7):649–652. doi: 10.1136/jcp.47.7.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Friis S., Kjaer S. K., Frisch M., Mellemkjaer L., Olsen J. H. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata. J Infect Dis. 1997 Apr;175(4):743–748. doi: 10.1086/513966. [DOI] [PubMed] [Google Scholar]
  23. Ham J., Dostatni N., Gauthier J. M., Yaniv M. The papillomavirus E2 protein: a factor with many talents. Trends Biochem Sci. 1991 Nov;16(11):440–444. doi: 10.1016/0968-0004(91)90172-r. [DOI] [PubMed] [Google Scholar]
  24. Harvey J. M., Glen E., Watson G. S. Buschke-Lewenstein tumour of the penis. A case report. Br J Vener Dis. 1983 Aug;59(4):273–276. doi: 10.1136/sti.59.4.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Herod J. J., Shafi M. I., Rollason T. P., Jordan J. A., Luesley D. M. Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women. Br J Obstet Gynaecol. 1996 May;103(5):446–452. doi: 10.1111/j.1471-0528.1996.tb09771.x. [DOI] [PubMed] [Google Scholar]
  26. Jacobs M. V., Snijders P. J., van den Brule A. J., Helmerhorst T. J., Meijer C. J., Walboomers J. M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997 Mar;35(3):791–795. doi: 10.1128/jcm.35.3.791-795.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jones C. J., Brinton L. A., Hamman R. F., Stolley P. D., Lehman H. F., Levine R. S., Mallin K. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res. 1990 Jun 15;50(12):3657–3662. [PubMed] [Google Scholar]
  28. Jones R. W. The natural history of vulvar intraepithelial neoplasia. Br J Obstet Gynaecol. 1995 Oct;102(10):764–766. doi: 10.1111/j.1471-0528.1995.tb10839.x. [DOI] [PubMed] [Google Scholar]
  29. Kinoshita T., Shirasawa H., Shino Y., Moriya H., Desbarats L., Eilers M., Simizu B. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein. Virology. 1997 May 26;232(1):53–61. doi: 10.1006/viro.1997.8536. [DOI] [PubMed] [Google Scholar]
  30. Koller L. D., Olson C. Attempted transmission of warts from man, cattle, and horses and of deer fibroma, to selected hosts. J Invest Dermatol. 1972 Jun;58(6):366–368. doi: 10.1111/1523-1747.ep12540579. [DOI] [PubMed] [Google Scholar]
  31. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996 Oct 21;69(5):364–368. doi: 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  32. Lusky M., Fontane E. Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6363–6367. doi: 10.1073/pnas.88.14.6363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Maddox P., Szarewski A., Dyson J., Cuzick J. Cytokeratin expression and acetowhite change in cervical epithelium. J Clin Pathol. 1994 Jan;47(1):15–17. doi: 10.1136/jcp.47.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Massimi P., Banks L. Repression of p53 transcriptional activity by the HPV E7 proteins. Virology. 1997 Jan 6;227(1):255–259. doi: 10.1006/viro.1996.8315. [DOI] [PubMed] [Google Scholar]
  35. Melero I., Singhal M. C., McGowan P., Haugen H. S., Blake J., Hellstrom K. E., Yang G., Clegg C. H., Chen L. Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16. J Virol. 1997 May;71(5):3998–4004. doi: 10.1128/jvi.71.5.3998-4004.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Meyers C., Mayer T. J., Ozbun M. A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J Virol. 1997 Oct;71(10):7381–7386. doi: 10.1128/jvi.71.10.7381-7386.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nakagawa M., Stites D. P., Farhat S., Sisler J. R., Moss B., Kong F., Moscicki A. B., Palefsky J. M. Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis. 1997 Apr;175(4):927–931. doi: 10.1086/513992. [DOI] [PubMed] [Google Scholar]
  38. Nardelli-Haefliger D., Roden R. B., Benyacoub J., Sahli R., Kraehenbuhl J. P., Schiller J. T., Lachat P., Potts A., De Grandi P. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect Immun. 1997 Aug;65(8):3328–3336. doi: 10.1128/iai.65.8.3328-3336.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Partridge E. E., Murad T., Shingleton H. M., Austin J. M., Hatch K. D. Verrucous lesions of the female genitalia. I. Giant condylomata. Am J Obstet Gynecol. 1980 Jun 15;137(4):412–418. doi: 10.1016/0002-9378(80)91120-5. [DOI] [PubMed] [Google Scholar]
  40. Pim D., Collins M., Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene. 1992 Jan;7(1):27–32. [PubMed] [Google Scholar]
  41. Ratcliffe M. A., Dawson A. A., Flannelly G. Progression of borderline abnormalities on cervical smear testing. BMJ. 1992 Jun 27;304(6843):1691–1691. doi: 10.1136/bmj.304.6843.1691-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Roberts S., Ashmole I., Rookes S. M., Gallimore P. H. Mutational analysis of the human papillomavirus type 16 E1--E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments. J Virol. 1997 May;71(5):3554–3562. doi: 10.1128/jvi.71.5.3554-3562.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schiffman M. H., Brinton L. A. The epidemiology of cervical carcinogenesis. Cancer. 1995 Nov 15;76(10 Suppl):1888–1901. doi: 10.1002/1097-0142(19951115)76:10+<1888::aid-cncr2820761305>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  44. Schiller J. T., Lowy D. R. Papillomavirus-like particles and HPV vaccine development. Semin Cancer Biol. 1996 Dec;7(6):373–382. doi: 10.1006/scbi.1996.0046. [DOI] [PubMed] [Google Scholar]
  45. Smith J. R., Kitchen V. S., Botcherby M., Hepburn M., Wells C., Gor D., Forster S. M., Harris J. R., Steer P., Mason P. Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet Gynaecol. 1993 Feb;100(2):149–153. doi: 10.1111/j.1471-0528.1993.tb15211.x. [DOI] [PubMed] [Google Scholar]
  46. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect. 1998 Feb;74(1):11–19. doi: 10.1136/sti.74.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sonnex C., Scholefield J. H., Kocjan G., Kelly G., Whatrup C., Mindel A., Northover J. M. Anal human papillomavirus infection: a comparative study of cytology, colposcopy and DNA hybridisation as methods of detection. Genitourin Med. 1991 Feb;67(1):21–25. doi: 10.1136/sti.67.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Stöppler H., Hartmann D. P., Sherman L., Schlegel R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem. 1997 May 16;272(20):13332–13337. doi: 10.1074/jbc.272.20.13332. [DOI] [PubMed] [Google Scholar]
  49. Tong X., Howley P. M. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4412–4417. doi: 10.1073/pnas.94.9.4412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wideroff L., Schiffman M. H., Hoover R., Tarone R. E., Nonnenmacher B., Hubbert N., Kirnbauer R., Greer C. E., Lorincz A. T., Manos M. M. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women. J Infect Dis. 1996 Nov;174(5):937–943. doi: 10.1093/infdis/174.5.937. [DOI] [PubMed] [Google Scholar]
  51. Wideroff L., Schiffman M. H., Nonnenmacher B., Hubbert N., Kirnbauer R., Greer C. E., Lowy D., Lorincz A. T., Manos M. M., Glass A. G. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis. 1995 Dec;172(6):1425–1430. doi: 10.1093/infdis/172.6.1425. [DOI] [PubMed] [Google Scholar]
  52. Zerfass-Thome K., Zwerschke W., Mannhardt B., Tindle R., Botz J. W., Jansen-Dürr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 1996 Dec 5;13(11):2323–2330. [PubMed] [Google Scholar]
  53. de Gruijl T. D., Bontkes H. J., Walboomers J. M., Stukart M. J., Robbesom A. A., von Blomberg-van der Flier B. M., Herbrink P., Remmink A. J., Verheijen R. H., Helmerhorst T. J. Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. Int J Cancer. 1996 Dec 11;68(6):731–738. doi: 10.1002/(SICI)1097-0215(19961211)68:6<731::AID-IJC7>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES